The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents.
Renal impairment (RI) is associated with impaired prognosis in patients with coronary artery disease. Clinical and angiographic outcomes of patients undergoing percutaneous coronary intervention (PCI) with the use of drug-eluting stents (DES) in this patient population are not well established.We po...
Main Authors: | Giulio G Stefanini, Masanori Taniwaki, Bindu Kalesan, Lorenz Räber, Stefan Stortecky, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W Serruys, Bernhard Meier, Peter Jüni, Stephan Windecker |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4153613?pdf=render |
Similar Items
-
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention.
by: Thomas Pilgrim, et al.
Published: (2014-01-01) -
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study.
by: Anna Franzone, et al.
Published: (2017-01-01) -
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01) -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01) -
Antibiotic eluting sinus stents
by: Harrison M. Thompson, et al.
Published: (2020-08-01)